Featured
The Biological Bottleneck: How Genomic Sovereignty, In Vivo Editing, and Algorithmic Epidemiology Are Restructuring Global Health Economics
October 2026 marks a definitive paradigm shift in public health as the WHO escalates the Mpox PHEIC, the FDA approves in vivo CRISPR therapies, and th...
Read Full Story →